Development and validation of the hypersomnia-specific beliefs scale
Development and validation of the hypersomnia-specific beliefs scale
复制标题
DOI：
10.1016/j.sleep.2020.06.012
复制
发表时间：
2020-11-01
期刊：
影响因子：
4.8
通讯作者：
Honda, Makoto
中科院分区：
文献类型：
--
作者：
Hazumi, Megumi;Ito, Wakako;Honda, Makoto
目的/背景：中枢性嗜睡症患者，特别是1型发作性睡病和特发性嗜睡症（NT 1和IHS）患者在日常生活中经常会出现心理挫折。方法：通过对11例NT 1和IHS患者的访谈，建立了由“对瞌睡的厌恶”、“对他人的过敏”、“对我瞌睡的反应”和“因瞌睡而产生的挫败感”3个因素组成的12个条目的HSB量表。HSB的有效性和可靠性进行了评估横截面与166例NT 1和IHS和375名对照组。同时采用患者健康问卷-2（PHQ-2）、简易社交恐怖量表（Mini-Social Phobia Inventory结果：三因素模型具有足够的拟合度（chi（2）= 60.25，df = 51，p = 0.18，TLI = 0.99，CFI = 0.99，RMSEA = 0.03），Cronbach α系数为0.90。组内相关系数为0.76。此外，受试者工作特征曲线下的面积（AUC = 0.88）证实了良好的辨别能力。临界值为38，敏感性为90%，特异性为75%。多元线性回归分析显示，这些量表与HSB评分独立相关; PHQ-2（β = 0.24，p = 0.002），mini-SPIN（β = 0.29，p < 0.001）和ESS结论：HSB量表测量NT 1和IHS患者的信念具有良好的效度、信度和区分能力。HSB量表评估NT 1和IHS专利特有的负面信念。该量表可用于开发NT 1和IHS患者的新的心理治疗方法。(c)2020 Elsevier B. V.保留所有权利。
Objective/Background: Patients with Central hypersomnia, especially Narcolepsy type 1 and Idiopathic Hypersomnia (NT1 and IHS) often have psychological frustration in their daily lives. We aimed to develop the first scale of hypersomnia-specific beliefs (HSB).Patients/methods: We developed the HSB scale consisting of three factors ("aversion toward doze", "hypersensitivity toward others" reactions about my doze", and "sense of defeat caused by doze") with 12 items through interviews to 11 patients with NT1 and IHS. Validity and reliability of the HSB were evaluated cross-sectionally with 166 patients with NT1 and IHS and 375 controls. Simultaneously, scores of patient health questionnaire-2(PHQ-2), mini-Social Phobia Inventory (mini-SPIN), and Epworth Sleepiness Scale (ESS) were obtained.Results: This 3-factor model had enough fitness (chi(2) = 60.25, df = 51, p = 0.18, TLI = 0.99, CFI = 0.99, RMSEA = 0.03), Cronbach's alpha coefficient being 0.90. The intraclass correlation coefficient was 0.76. Also, the area under the receiver operating characteristic curve (AUC = 0.88) confirmed good discrimination ability. A cut-off score of 38 resulted in a sensitivity of 90% and a specificity of 75%. Multiple linear regression analyses showed that these scales were independently associated with the HSB score; the PHQ-2 (beta = 0.24, p = 0.002), mini-SPIN (beta = 0.29, p < 0.001) and ESS (beta = 0.15, p = 0.048).Conclusions: Our data suggest that the HSB scale measured beliefs in NT1 and IHS patients with good validity, reliability, and discrimination ability. The HSB scale assesses the negative beliefs specific to patents with NT1 and IHS. This scale could be applied to the development of novel psychotherapeutic approach to patients with NT1 and IHS. (c) 2020 Elsevier B.V. All rights reserved.